Research sites, site networks, hospitals and academic medical centers choosing a CTMS to run their own studies, participant visits and site finances. Sponsor and CRO CTMS products are out of scope.
Scope This list serves research sites, not sponsors and CROs. A site CTMS runs participant visits, site budgets and sponsor invoicing; a sponsor or CRO CTMS oversees many sites and countries (monitoring, country start-up, portfolio views). Their workflows differ, so sponsor and CRO products (Veeva Vault CTMS, Oracle Siebel CTMS, Medidata CTMS, IQVIA) belong on a separate list with their own criteria. Products that support participant follow-up alongside a site CTMS are also included; the feature notes distinguish this from dedicated CTMS operations.
These notes describe the products in the CTMS guide.
Advarra OnCore
Best for
Academic medical centers, NCI-designated cancer centers and health systems running 50 to 500+ active trials on Epic or Cerner.
What to consider
OnCore documents site finances, billing compliance and EHR integration. A January 2026 University of Arkansas for Medical Sciences release says it is used by 80% of NCI-designated cancer centers. It is built for large, centralized research offices, not small independent sites.
Independent research sites and site networks that want CTMS, eSource, eReg and participant payments from one vendor.
What to consider
RealTime pairs strong participant and visit tracking with a full set of its own site tools. It publishes no customer count or prices and lists no EHR integration.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
Advarra OnCore vs RealTime-CTMS (CTMS): category feature evidence and sources. Products are not ranked.
Category feature
Advarra OnCore
RealTime-CTMS
Study, participant and visit trackingFeature definitions
Supported
Study participants or visits can be tracked.
Extended support
Participant outreach or pre-screening plus visit scheduling are documented.
Advarra OnCore
Supported
OnCore builds protocol calendars and automatic subject calendars for visit tracking and integrates with Epic, but public material does not describe recruitment or pre-screening tools.
Visit calendars establish base support; recruitment and pre-screening are not described.
RealTime-CTMS
Extended support
RealTime-CTMS tracks subjects from referral to completion, calculates visit target dates with window enforcement, and supports recruitment database queries and pre-screening tracking.
Recruitment queries and pre-screening combine with visit target dates and window enforcement.
Site financesFeature definitions
Supported
Study budgets, invoicing, receivables or payment reconciliation are documented.
Extended support
Study finance workflows include research billing designations or billing-grid links to an EHR.
Advarra OnCore
Extended support
OnCore covers budget creation and negotiation, automated invoicing and payment reconciliation, and records billing designations per visit or procedure with a qualifying clinical trial checklist.
Budgeting, invoicing and reconciliation include visit/procedure billing designations and a trial checklist.
RealTime-CTMS
Supported
It tracks budgets, completed visits, invoices with aging reports, receivables, payables and subject stipends through SitePay, but RealTime does not describe research billing compliance features.
Named client evidence establishes base adoption without a published customer or site count.
Compliance and securityFeature definitions
Supported
Relevant trial compliance or security controls are stated, with their scope identified.
Extended support
Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
Advarra OnCore
Supported
Advarra states its cloud-based technology holds ISO 27001:2013 and SOC 2 Type 2 certification, but it claims Part 11 for its eReg and EDC rather than the CTMS and makes no HIPAA statement for OnCore.